↓ Skip to main content

Dove Medical Press

Enhanced bioavailability and anthelmintic efficacy of mebendazole in redispersible microparticles with low-substituted hydroxypropylcellulose

Overview of attention for article published in Drug Design, Development and Therapy, September 2014
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (54th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

patent
1 patent

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
42 Mendeley
Title
Enhanced bioavailability and anthelmintic efficacy of mebendazole in redispersible microparticles with low-substituted hydroxypropylcellulose
Published in
Drug Design, Development and Therapy, September 2014
DOI 10.2147/dddt.s65561
Pubmed ID
Authors

Paloma Marina de la Torre-Iglesias, Juan José García-Rodriguez, Guillermo Torrado, Susana Torrado, Santiago Torrado-Santiago, Francisco Bolás-Fernández

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 42 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 42 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 12%
Student > Ph. D. Student 3 7%
Researcher 3 7%
Professor > Associate Professor 3 7%
Professor 3 7%
Other 10 24%
Unknown 15 36%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 8 19%
Agricultural and Biological Sciences 4 10%
Chemistry 3 7%
Biochemistry, Genetics and Molecular Biology 3 7%
Materials Science 2 5%
Other 7 17%
Unknown 15 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 May 2023.
All research outputs
#8,535,472
of 25,374,647 outputs
Outputs from Drug Design, Development and Therapy
#642
of 2,268 outputs
Outputs of similar age
#82,109
of 248,671 outputs
Outputs of similar age from Drug Design, Development and Therapy
#19
of 49 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,268 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 248,671 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.
We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.